[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

AU2001284434A1 - Granular preparations for oral administration - Google Patents

Granular preparations for oral administration

Info

Publication number
AU2001284434A1
AU2001284434A1 AU2001284434A AU8443401A AU2001284434A1 AU 2001284434 A1 AU2001284434 A1 AU 2001284434A1 AU 2001284434 A AU2001284434 A AU 2001284434A AU 8443401 A AU8443401 A AU 8443401A AU 2001284434 A1 AU2001284434 A1 AU 2001284434A1
Authority
AU
Australia
Prior art keywords
oral administration
taking
granular preparations
grain
feeling
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001284434A
Other languages
English (en)
Inventor
Tatsuo Nomura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Pharma Corp
Original Assignee
Mitsubishi Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Pharma Corp filed Critical Mitsubishi Pharma Corp
Publication of AU2001284434A1 publication Critical patent/AU2001284434A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A61K31/787—Polymers containing nitrogen containing heterocyclic rings having nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047—Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001284434A 2000-09-06 2001-09-05 Granular preparations for oral administration Abandoned AU2001284434A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2000269526 2000-09-06
JP2000-269526 2000-09-06
PCT/JP2001/007697 WO2002019993A1 (fr) 2000-09-06 2001-09-05 Preparations de granules pour administration orale

Publications (1)

Publication Number Publication Date
AU2001284434A1 true AU2001284434A1 (en) 2002-03-22

Family

ID=18756115

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001284434A Abandoned AU2001284434A1 (en) 2000-09-06 2001-09-05 Granular preparations for oral administration

Country Status (11)

Country Link
US (1) US7964218B2 (de)
EP (1) EP1323418B1 (de)
JP (1) JP3883505B2 (de)
KR (1) KR100790056B1 (de)
CN (1) CN1250205C (de)
AT (1) ATE476968T1 (de)
AU (1) AU2001284434A1 (de)
CA (1) CA2421240C (de)
DE (1) DE60142789D1 (de)
ES (1) ES2350307T3 (de)
WO (1) WO2002019993A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101767288B1 (ko) 2010-03-31 2017-08-10 모찌다 세이야쿠 가부시끼가이샤 복용 용이성 고형 제제
CA2847614C (en) 2011-09-30 2018-10-23 Mochida Pharmaceutical Co., Ltd. Easily dosable solid preparation
CN105476969A (zh) * 2015-12-18 2016-04-13 北京万全德众医药生物技术有限公司 考来替兰分散片及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4999189A (en) * 1988-11-14 1991-03-12 Schering Corporation Sustained release oral suspensions
DE59000232D1 (de) 1989-02-11 1992-09-10 Bayer Ag Arzneimittel mit kontrollierter wirkstoffabgabe.
IT1246382B (it) 1990-04-17 1994-11-18 Eurand Int Metodo per la cessione mirata e controllata di farmaci nell'intestino e particolarmente nel colon
CA2129079C (en) 1993-08-03 2006-01-17 Tatsuo Nomura Orally administrable cholesterol lowering agent
EP0811374A1 (de) * 1996-05-29 1997-12-10 Pfizer Inc. Formulierung für ein Kombinationspräparat mit Cetirizin und Pseudoephedrin
GB9620709D0 (en) * 1996-10-04 1996-11-20 Danbiosyst Uk Colonic delivery of weak acid drugs
JP4010585B2 (ja) * 1996-10-15 2007-11-21 久光製薬株式会社 陰イオン交換樹脂を含有する錠剤
US6066336A (en) * 1997-09-29 2000-05-23 Bristol-Myers Squibb Company Cholesterol-lowering tablets
US6174873B1 (en) * 1998-11-04 2001-01-16 Supergen, Inc. Oral administration of adenosine analogs

Also Published As

Publication number Publication date
JPWO2002019993A1 (ja) 2004-01-15
ATE476968T1 (de) 2010-08-15
US20040101567A1 (en) 2004-05-27
EP1323418A1 (de) 2003-07-02
CN1452480A (zh) 2003-10-29
CA2421240C (en) 2010-03-23
ES2350307T3 (es) 2011-01-20
CA2421240A1 (en) 2003-03-05
KR100790056B1 (ko) 2007-12-31
WO2002019993A8 (fr) 2003-11-13
JP3883505B2 (ja) 2007-02-21
US7964218B2 (en) 2011-06-21
EP1323418A4 (de) 2007-05-30
EP1323418B1 (de) 2010-08-11
DE60142789D1 (de) 2010-09-23
WO2002019993A1 (fr) 2002-03-14
KR20030036756A (ko) 2003-05-09
CN1250205C (zh) 2006-04-12

Similar Documents

Publication Publication Date Title
CA2360236A1 (en) Sulfoalkyl ether cyclodextrin based controlled release solid pharmaceutical formulations
CA2371940A1 (en) Pregelatinized starch in a controlled release formulation
CA2358493A1 (en) Edible coating composition
AU5680100A (en) Controlled release and taste masking oral pharmaceutical compositions
WO2002072033A3 (en) Chronotherapeutic dosage forms containing glucocorticosteroid
JP2008540649A5 (de)
CA2307018A1 (en) Osmotic medicament releasing system
SI0868912T1 (en) Use of redispersible polymer powders or polymer granulates for coating pharmaceutical or agrochemical delivery forms
CA2346988A1 (en) Pharmaceutical formulation comprising omeprazole
CA2277017A1 (en) Rapidly releasing and taste-masking pharmaceutical dosage form
WO2006124366A3 (en) Flavoring of drug-containing chewing gums
CA2281420A1 (en) Preparation of pharmaceutically-active granules
CA2295035A1 (en) Pharmaceutical formulations containing voriconazole
MXPA03001855A (es) Composiciones peliculares de pectina.
WO2001052651A3 (en) Particulate blends and compacted products formed therefrom, and the preparation thereof
EP1317916A3 (de) Filme enthaltend modifizierte Stärke
CA2251886A1 (en) An oral pharmaceutical formulation containing ibandronate
BG108516A (en) Pharmaceutical formulation
EP1177788A3 (de) Fluoxetin-Arzneimittel in Form überzogener dispergierbarer Tabletten sowie Verfahren zu dessen Herstellung
MXPA03008420A (es) Forma farmaceutica solida oralmente dispersa.
AU6211501A (en) Dental care agents provided in the form of single-portion capsules
EP0931545A3 (de) Droloxifen pharmazeutische Zusammenstellung
WO2003000225A3 (fr) Formulation pharmaceutique au gout masque et son procede de preparation
AU2001284434A1 (en) Granular preparations for oral administration
WO2002049607A3 (en) Flavoured oral drug delivery system